ElizabethBerry-KravisMD
Child Neurology • Chicago, ILProfessor, Pediatrics, Rush Medical College of Rush Univ
Dr. Berry-Kravis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison St
Ste 710
Chicago, IL 60612Phone+1 312-942-3034
Education & Training
University of ChicagoResidency, Neurology, 1987 - 1990- University of ChicagoResidency, Pediatrics, 1985 - 1987
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Certifications & Licensure
IL State Medical License 1987 - 2026- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
- Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
- A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Aortic Root Dilation and Genotype Associations in Phelan-McDermid Syndrome.Jake Gluckman, Tess Levy, Kate Friedman, Francesca Garces, Rajna Filip-Dhima
American Journal of Medical Genetics. Part A. 2025-01-01 - Deep functional measurements of Fragile X syndrome human neurons reveal multiparametric electrophysiological disease phenotype.James J Fink, Nathaniel Delaney-Busch, Ryan Dawes, Evanthia Nanou, Christopher Folts
Communications Biology. 2024-11-06 - Auditory N1 event-related potential amplitude is predictive of serum concentration of BPN14770 in fragile X syndrome.Jordan E Norris, Elizabeth M Berry-Kravis, Mark D Harnett, Scott A Reines, Melody A Reese
Molecular Autism. 2024-11-02
Authored Content
- Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
- Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
- Long-Term Treatment of Niemann-Pick Type C1 Disease with Intrathecal 2-Hydroxypropyl-Β-cyclodextrinJanuary 2018
Press Mentions
Experimental Drug Signals Hope for Fragile X SyndromeOctober 1st, 2024
Investigational Drug for Fragile X Syndrome Improves CognitionSeptember 24th, 2024
Rush Named Batten Disease Clinical Center of ExcellenceAugust 14th, 2024- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
